Kim Sablich, Chief Commercial Officer at Myovant Sciences Ltd. (MYOV), sold 2,585 shares at $16.22 ($42K) on 2019-12-18, disclosed to the SEC on 2019-12-19.
Open-market sale of $42k MYOV by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| JAZZ | SELL | 2021-11-15 | $742K | — | Filing → |
| MYOV | SELL | 2020-03-19 | $6K | — | Filing → |
| MYOV | SELL | 2020-01-16 | $136K | — | Filing → |